Feeds:
Posts
Comments

Archive for the ‘from the consulting room’ Category

There’s an organisation in England known as NICE – The National Institute for Health and Clinical Excellence. Many countries have their equivalent organisations. Their job is to inform health service policy but in fact their advice tends to be taken as the definitive word……if NICE says “no” then that drug will NOT be available on the NHS.

Their decisions cause controversy. Most recently they’ve been in the news over treatments for a cause of blindness and anticancer drugs which are indicated for kidney cancer. In trying to defend their decisions I’ve seen NICE spokesmen struggling to insist that they don’t make a decision on the basis of cost, but on “clinical cost effectiveness”. What does this mean?

Across on the NICE website you can find a very clear explanation. It’s all about QALYs – Quality Adjusted Life Years. This is an international formula for calculating the cost of improving the length and quality of a person’s life. Here’s the detail – (the FULL detail) –

Although one treatment might help someone live longer, it might also have serious side effects. (For example, it might make them feel sick, put them at risk of other illnesses or leave them permanently disabled.) Another treatment might not help someone to live as long, but it may improve their quality of life while they are alive (for example, by reducing their pain or disability).

The QALY method helps us measure these factors so that we can compare different treatments for the same and different conditions. A QALY gives an idea of how many extra months or years of life of a reasonable quality a person might gain as a result of treatment (particularly important when considering treatments for chronic conditions)..

A number of factors are considered when measuring someone’s quality of life, in terms of their health. They include, for example, the level of pain the person is in, their mobility and their general mood. The quality of life rating ranges from 0 (worst possible health) to 1 (the best possible health). (See the box below for an example of how this works in practice.)

What about cost effectiveness?

Having used the QALY measurement to compare how much someone’s life can be extended and improved, we then consider cost effectiveness – that is, how much the drug or treatment costs per QALY. This is the cost of using the drugs to give someone an additional year of life..

Cost effectiveness is expressed as ‘£ per QALY’.

Each drug is considered on a case-by-case basis. Generally, however, if a treatment costs more than £20,000-30,000 per QALY, then it would not be considered cost effective.

How a QALY is calculated

Patient x has a serious, life-threatening condition.

  • If he continues receiving standard treatment he will live for 1 year and his quality of life will be 0.4 (0 = worst possible health, 1= best possible health)
  • If he receives the new drug he will live for 1 year 3 months (1.25 years), with a quality of life of 0.6.

The new treatment is compared with standard care in terms of the QALYs gained:

  • Standard treatment: 1 (year’s extra life) x 0.4 = 0.4 QALY
  • New treatment: 1.25 (1 year, 3 months extra life) x 0.6 = 0.75 QALY

Therefore, the new treatment leads to 0.35 additional QALYs (that is: 0.75 –0.4 QALY = 0.35 QALYs).

  • The cost of the new drug is assumed to be £10,000, standard treatment costs £3000.

The difference in treatment costs (£7000) is divided by the QALYs gained (0.35) to calculate the cost per QALY. So the new treatment would cost £20,000 per QALY.

—————————————————————————————–

What do you think about this?

I think it’s riddled with problems!

In reality, nobody can tell how many months of life any particular individual human being will live. In fact, the greater the length of the prediction, the less accurate it is. So, not only are we unable to predict accurately how long a person with a particular disease will live, we are also unable to predict how long a person with a particular disease will live if they take a particular treatment. We can work out the averages, work out the probabilities, but we cannot KNOW these figures for any single real person. The use of definite figures such as “8 months without treatments and 13 months with drug X” convey a false sense of certainty. They pretend to be “scientific” and therefore some kind of believable truth. But they are guesses. Informed guesses no doubt, but guesses none the less. If YOU are the patient, are you prepared to make your decisions on the basis of what happens to the statistical average person? Or do you still hope that you might be one of the people who do better than the average? After all, there are always people who will have a better than average experience and nobody can tell you whether or not you are going to be one of those people.

So, the QALY is based on an estimate of a life course. The length of life part of the calculation is a guess. It always is.

Secondly, what about the “quality” part? Who decides that on a scale of 0 to 1 (0=death and 1=perfect health) your quality of life can be assessed as 0.4 or 0.8 or whatever? The questionnaires used have been heavily criticised for picking life values which the authors of the questionnaires rate as important, not the life values which a particular patient might have. Who, in fact, can judge quality of life better than the person whose life it is?

These are not only my criticisms – here are few from the National Library of Health

  1. Values assigned to the quality of life component of the QALY may not reflect the values of patients receiving the interventions.
  2. They may lack sensitivity in some disease areas.  For example for chronic disease or mental illness, as quality of life measures largely focus on physical rather than psychological or social disability.
  3. Some feel that QALYs can over-simplify complex healthcare issues and suggest ‘quick and easy’ resource allocation decision.
  4. In QALYs, all the emphasis is placed on the size of the health improvement, without taking into consideration the starting point.
  5. There is an issue with distribution – it is thought that the QALY approach maximises total welfare without regard to how such welfare is distributed between people.
  6. There is also criticism that conventional QALYs don’t account for attitudes towards risk.
  7. There are several technical assumptions that are implicit within the QALY model, and there is evidence that these do not accurately reflect real life

But my doubts don’t stop there. Did you read the part about considering the actual cost of the QALY? £20,000 – £30,000 is the limit. If a treatment costs more than that, then it will not be allowed. Who decided that? Why not £10,000 – £20,000? Or £30,000 – £50,000? Doesn’t this make you uncomfortable? That we decide whether or not a treatment should be available on the basis of this financial limit? It certainly makes me uncomfortable. Should we accept that there has to be a limit at all? We make plenty of other decisions as a society about how money is spent without considering these kinds of limits – fighting wars in Iraq, Afghanistan, building nuclear missiles which know will destroy us all if we use them, paying some footballers more than £30,000 a week, increasing economic inequality…….you can choose your own pet spending decision.

We do need a debate about all of this, but let me ask you to think about this. If the patient with the disease under consideration is someone you love, someone you really, really care about, will you still be happy to accept a decision on the basis of QALYs?

Read Full Post »

The dominant concept of disease is still a lesional one. The first task for a doctor is to diagnose. This should mean “to understand” or “to explain” but the way doctors are educated and trained gives priority to pathology ie to disease within cells, tissues or organs. Almost all the technologies used to “diagnose” aim to illuminate and/or identify a physical lesion. So, when you present to your doctor with some disturbing symptoms, he or she will set off on a hunt for the physical lesion. If they find a pathology, they will use their knowledge and experience to settle upon a conclusion that your symptoms are the manifestation of that pathology. Treatments offered will be chosen according to this understanding. The intention of the treatment is to either remove the pathology or to act against the symptoms which the pathology is assumed to be producing.

But what happens if there is no physical lesion? If the “diagnosis” from either the story and the physical examination, or from the “normal” findings produced by the investigative instruments, excludes (or, more realistically, fails to identify) any pathology, any physical lesion? Well, the default is to say the problem lies in the mind. In other words, there are two options – either a physical cause, or a psychological/psychiatric one.

This model is creaking at the seams. Increasingly we are demonstrating how diseases do not fall into one of those two neat compartments. The symptoms experienced, and the sense a patient makes of those symptoms, usually involves both the body and the mind.

If you’ve ever had pain which lasts for some time, you’ll know how that affects every aspect of your life. If part of your body doesn’t work because of damage to nerve fibres, then living with the resulting paralysis affects every aspect of your life. The simplistic view is that if the physical cause is treated the psychological distress will just go away. Life actually isn’t that simple!

The other direction is explored through psychosomatic medicine – the physical manifestion of the diseases of the mind. If you are anxious, or depressed, then your physical body is affected – breathlessness, pain, diarrhoea, palpitations etc etc.

As we improve our understanding of human beings, we discover that this old “cartesian” model is not as helpful as we used to think. Problems which have a focus in the body affect the mind and vice versa. In fact the body and the mind are so intricately interconnected that it would be rare for a problem to be so isolated into one of our “compartments”!

I’ve written before about some of the interesting work on the links between symptoms and diseases – see the posts about Meaning-full Disease and Why Do People Get Ill?

It’s also true that as human beings are intensely social beings, that sometimes the problem lies not within a single being but within a relationship, a family, or a community – see the work of Eric Cassell who has illuminated a lot of this by focusing on the patient’s “suffering”; and the work of Wilkinson on inequality.

However, let me postulate another explanation – maybe sometimes the problem lies in the “system”. Thanks to the explanatory model of the complex adaptive system, we now see that an organism can dysfunction, not because single parts of it have gone wrong but because the way everything works together has become damaged or disordered. This is still a new idea in medicine. There aren’t any scientific tests to help us “diagnose” such a problem. But look at all those chronic disorders where no lesions are found and there is really not a reasonable psychological explanation either. The fact that many people are ill without lesions and without psychological disorders shows us that there is something else going on which we have so far failed to grasp. This should undermine those who make psychological diagnoses in everyone who has normal “tests”! It’s intensely frustrating for an ill person to not be taken seriously or to be told that something is “all in your head”.

Read Full Post »

logic of care

The Logic of Care by Annemarie Mol, Professor of Political Philosophy, University of Twente, Netherlands ISBN 978-0-415-45343-1

Every now and then I read something which challenges my thinking. This is one of those books. The subtitle of the book is “Health and the Problem of Patient Choice”. I thought, “what problem?”, by which I mean isn’t it just a “good thing”? Aren’t we hearing this mantra increasingly often? That the way ahead for health care is to increase patient choice? Wasn’t this even what was implied by my post about the shift in power from doctors to patients? Yet, one of the commenters on that post made me feel immediately uncomfortable because they highlighted the issue of patients being seen as “customers”, which just doesn’t feel right to me. In fact, I’ve often felt I’m a bit out of step with new terminologies because I don’t like “patients” being referred to as “clients” or “customers” or any of the other preferred modern terms! However, right from the outset, Annemarie Mol questions our “logic of choice” – not only in health care, but in society more generally. She points out that in society, the emphasis on choice is not all that it seems. If, like me, you haven’t thought much about this before, this questioning of “the logic of choice” is challenging…..

“Sociologists have emphasised that all humans are born naked and helpless and depend on others for their survival for years. Even as adults Westerners are independent – all the more since they no longer cultivate their own food, sew their own clothes, or bury their own dead. Some sociologists have studied how in actual practice people in “free societies” make their choices. They have found that making choices takes a lot of energy, energy that not everybody has to spare or likes to spend on it. They have also found that “we” end up choosing remarkably similar things. Indeed, some scholars have argued that autonomy is not the opposite of heteronomy at all. Instead, they say, making people long for choices and invest a lot in making them, is a disciplining technique.”

“A second widespread way of doubting the ideal of choice is to point out that when it comes to it almost nobody (ill or healthy) is any good at it. It is difficult for all of us to weigh up the advantages and disadvantages of one uncertain future against another.”

As she points out, when somebody is acutely ill, they aren’t in a position to make choices. Instead, she says, what they need most is care. She shows how the logic of choice presupposes which finite and distinct products, instruments, outcomes, and so on are on offer. Having chosen, the patient awaits the promised outcome. In the logic of care the emphasis is on actions, interactions and processes. It isn’t about outcomes, it’s about experiences, or ways of living.

“Care is not a limited product, but an ongoing process”

“….consumers can help each other with their choices and they may buy as much kindness and attention as they can afford. However, and this is my point, in one way or another a market requires that the product that changes hands in a transaction be clearly defined. It must have a beginning and an end. In the logic of care, by contrast, care is an interactive, open-ended process that may be shaped and reshaped depending on its results. This difference is irreducible. It implies that a care process may improve even though less product is being supplied.”

The biggest problem with clinical epidemiology and the logic of choice approach is the unpredictable nature of reality.

“……diseased bodies are unpredictable. It follows form this unpredictability that care is not a well-delineated product, but an open-ended process. Try, adjust, try again. In dealing with a disease that is chronic, the care process is chronic too. It only ends the day you die.”

“Do not just pay attention to what technologies are supposed to do, but also to what they happen to do, even if this is unexpected. This means that good professionals need to ask patients about their experiences and attend carefully to what they are told, even if there is nothing about it in the clinical trial literature. There won’t be. The unexpected is not included in the design of trials. The parameters to be measured are laid out in the first stage of a clinical epidemiology research project. If doctors and nurses want to learn about the unexpected effects of interventions, they should treat every single intervention as yet another experiment. They should, again and again, be attentive to whatever it is that emerges.”

This unpredictability undermines the logic of the dominant approach to medicine –

“The scientific tradition that is currently most prominent in health care – that of clinical epidemiology – has not been designed to deal with the unexpected effects of interventions. Tracing these requires that one be open to surprises. Since unforeseen events cannot be foreseen and unidentified variables cannot be counted, other research methods are needed to learn more about them. Promising among these are the clinical interview and the case report. In good clinical interviews patients are granted time and space to talk about what they find striking, difficult or important. The diverse and surprising experiences are carefully attended to. Case reports in their turn are stories about remarkable events. They make these events transportable so that others may learn from them.”

And the answers are to be found in stories – in listening to patients and professionals and to reporting what is learned.

“The ideal of patient choice presupposes professionals who limit themselves to presenting facts and using instruments. In the linear unfolding of a consultation, a professional is supposed to give information, after which the patient can assess his or her values and come to a decision. Only then is it possible to act. However, care practices tend not to be linear at all. Facts do not precede decisions and activities, but depend on what is hoped for and on what can be done. Deciding to do something is rarely enough to actually achieve it. And techniques do more than just serve their function – they have an array of effects, some of which are unexpected. Thus, caring is a question of “doctoring”: of tinkering with bodies, technologies and knowledge – and with people, too.”

I like her emphasis on doctoring instead of technologies and products –

“I want to talk of doctoring. Within the logic of care engaging in care is a matter of doctoring. Doctoring again depends on being knowledgeable, accurate and skilful. But, added to that, it also involves being attentive, inventive, persistent and forgiving.”

And of her emphasis, not just on good communication –

“Good communication is a crucial precondition for good care. It also is care in and of itself. It improves people’s daily lives.”

…..not just communication, but “conversations” –

“Good conversations in a consulting room do not take the shape of a confrontation between arguments, but are marked by an exchange of experiences, knowledge, suggestions, words of comfort.”

“Let us doctor, and thus, in careful ways, experiment with our own lives. And let us tell each other stories. Case histories. Public life deserves to be infused with rich stories about personal events.”

Life is complex. Health is complex. It cannot be reduced to events, interventions, targets and outcomes. Patients are not consumers. The model of markets, goods, services, purchasers and providers may well NOT be the best one for health care. This is not least because people with chronic diseases need attention for life, but also because we all have a variety of different values and priorities which, themselves, will vary through the evolving different contexts of our lives.

“Clinical epidemiology has developed clinical trials as research tools to inquire into the effectiveness and effectivity of treatments. Clinical epidemiology itself however, relates to patient choice in an ambivalent way. Sometimes it indeed presents its trials as tools that increase knowledge of the “means” that doctors have at their disposal, suggesting that the “ends” can be established elsewhere. At other times, however, clinical epidemiology casts patient choice as superfluous. For if trials show which treatments are more effective and efficient than their alternatives, there is no further need to make decisions. Just go for the treatments the trials show to be best! To the adherents of this line of thought, it is a great puzzle: why do professionals not comply? Why do they refuse to implement the results of front-line clinical trials? There is a lot going on here, but let me just note that this question fails to recognise that the parameters explored in trials, their measures of success, do not necessarily map onto the ends that patients and their doctors may want to achieve. If there are different treatments, the question is not just which of them is more effective, but also which effects are more desirable. The question is not just which treatment has the greatest impact on a given parameter, but also which parameter to measure. In chronic diseases “health” is out of reach, so it is not obvious which parameter to go for. Different treatments may well improve different parameters. Or, to put it in the terms used in the logic of choice: not all technologies serve the same ends and not all ends are equally worthwhile to everyone concerned.”

“Some diseases can never be cured, some problems keep on shifting. Even if good care strives after good results, the quality of care cannot be deduced from its results. Instead, what characterises good care is a calm, persistent but forgiving effort to improve the situation of a patient, or to keep this from deteriorating.”

And, finally, I completely agree with her emphasis on acting – on what we DO

“The logic of care is not preoccupied with our will, and with what we may opt for, but concentrates on what we do.”

“Rather than taking you for a spectator of your life, they expect you to play a leading part in it. Thus, in the logic of care it is not the noun that is crucial, life (an object that can be judged), but rather the verb, to live (an activity of which we are the subjects).”

Read Full Post »

The BMJ this week reported an enormous increase in the amount of prescribed drugs being taken by people over 60 years old in England and Wales. In 1997, this group of the population were prescribed just over 22 items a year. 10 years on they are receiving just over 42 items a year. Overall, there has been a 50% increase in the average numbers of items prescribed per person. As you might expect, costs have shot up accordingly, doubling in the same decade – from £4.4billion in 1997 to £8.4billion in 2007. Statins in particular have gone up from under 5 million prescriptions in 1997 to 45 million last year.

Steve Field, chairman of the Royal College of General Practitioners, said that the increase in the number of prescriptions was probably due to a combination of a rising number of elderly people, more people with chronic conditions, and greater use of drugs used in preventive treatment.

The second report which caused me concern was a study by a Professor of Sociology who presented a paper at the American Sociological Association. He has demonstrated that the current licensing method which relies on trials of a drug against placebo, however,

Systematic reviews indicate that one in seven new drugs is superior to existing drugs, but two in every seven new drugs result in side effects serious enough for action by the U.S. Food and Drug Administration (FDA), including black box warnings, adverse reaction warnings, or even withdrawal of the drug.

So, he concludes, a new drug has twice as much chance of doing you harm than giving you greater benefit than the existing drugs.

Harms from prescribed medication are no small thing –

According to a 1999 report for the Institute of Medicine, adverse drug reactions (ADRs) are the fourth leading cause of death in the United States and more than two million serious reactions occur every year.

These two reports disturb me for two reasons. One is because they make me wonder just where medicine is going. Are we defining health as what people who take drugs experience? What’s normal any more? How successful are our societies where such large proportions of the population are having to swallow so many pills? This can’t be the best way to address the issue of Public or personal Health! Secondly, because of the extent to which the balance is tipping, not in favour of safer, more effective treatments, but, apparently in favour of more dangerous, and marginally (at best) more effective treatments.

Surely we need to think more seriously about how to maintain health and how to help people with chronic illnesses without reversion to drugs?

Read Full Post »

It’s funny how a document or an idea can float around for many years then re-emerge with new relevance much later. In reading about “Health 2.0” in the BMJ recently I followed the links to the Demos organisation and downloaded their excellent document “The Talking Cure“. One of the references listed in that document was a publication by the Royal Pharmaceutical Society of Great Britain, published back in 1997, tackling the issue of “non-compliance” – where patients don’t actually take their medicines as they’ve been prescribed. This is a fascinating document. The conclusion it reaches is that it’s time to stop thinking about “compliance” and start thinking about “concordance”.

Here’s their definition of “compliance” –

The patient presents with a significant medical problem for which there is a potentially helpful treatment. What the doctor or other health care professional brings to the situation – scientific evidence and technical expertise – is classed as the solution. What the patient brings – ‘health beliefs’ based on such qualities as culture, personality, family tradition and experience – is classed by clinicians as the impediment to the solution. The only sensible way out of this difficulty would appear to be to bring the patient’s response to the doctor’s diagnosis and proposed treatment, as far as possible into line with what medical science suggests.

and, here’s their definition of “concordance”

The clinical encounter is concerned with two sets of contrasted but equally cogent health beliefs – that of the patient and that of the doctor. The task of the patient is to convey her or his health beliefs to the doctor; and of the doctor, to enable this to happen. The task of the doctor or other prescriber is to convey his or her (professionally informed) health beliefs to the patient; and of the patient, to entertain these. The intention is to assist the patient to make as informed a choice as possible about the diagnosis and treatment, about benefit and risk and to take full part in a therapeutic alliance. Although reciprocal, this is an alliance in which the most important determinations are agreed to be those that are made by the patient.

This is such an important shift in thinking.

The full report considers what this means for “Evidence Based Medicine” (EBM). It does represent a challenge but it doesn’t undermine EBM principles. EBM is basically clinical epidemiology. It’s a statistical technique which focuses on the results of experiments conducted on groups of volunteers. It helps us to understand the potential of an intervention. However, the reality of an intervention has to be patient based. A painkiller might be “proven” in EBM terms, but might totally fail to relieve a particular patient’s pain. In fact, that’s partly the reason there are so many “proven” drugs which claim to do the same thing – they might have demonstrated their potential to something but only the patient can decide whether or not they “work” for them.

This is encouraging. For too long patients’ experiences have been dismissed as “anecdotal” and, frankly, irrelevant. That thinking has to change.

Read Full Post »

There’s a revolution beginning in the practice of medicine. It’s about a shift in power which will change the way doctors work. It’s quite fascinating to see the early shoots appearing and it’s way too early to be able to say exactly how this is going to develop.

One of the change factors is what is being termed “Health 2.0”. This term is being used in different ways but it mainly refers to the use of social networking tools. This is one of them – a blog. Blogs allow anybody to publish anything of interest. Some blogs are just websites trying to sell something, and some are so highly personal that they are only of interest to readers who already know the blog author. But the most exciting blogs are those which allow sharing of experiences, views, information through tools like links, tags, comments, blogrolls and so on. Social networking sites like Facebook, Myspace, Bebo and so on are other ways of sharing experiences views and information. I could go on, but I won’t! There are more and more tools emerging all the time. What do they have in common? They are about sharing. They allow people to access the stories of others’ experiences.

What’s this got to do with health?

Well, the traditional doctor-patient relationship is based on a doctor as the expert who knows best and a patient who will passively accept the doctor’s recommendations, whether that be a prescription or an operation or whatever. The power sits with the doctor and the patient often feels intimidated or unheard. The new way is patient-centred, another term which means different things to different people, but which usually includes giving a higher prioirty to the patient’s issues and wishes.

There are two elements to this “Health 2.0” change – doctor-patient communication and patient-patient communication. The US Institute of Medicine’s report “Crossing the Quality Chasm” suggested that care be seen in future as less “event based” and more “relationship based”. It recommended that doctors and other members of health care teams be more accessible to patients and that care becomes an ongoing process rather than conceived of as something that only happens in “consultations” or “office visits” or “admissions”. An article about these changes was published in the BMJ last week. It highlighted the need to shift towards what it called “conversations”, giving one example of moving the patient record from being a doctor-held property to being a document co-created and shared between doctor and patient –

An example of this conversation is that created when general practitioners share records with their patients by posting them on the web. It is being pioneered by a group of English GPs in the patient access electronic records collaborative, using the EMIS information system for primary care. GPs will post up the patient records on a password protected site and patients and their GP will be able to access them.

This sharing of information is a major driver in the shift of power. Not only will personal information no longer be the sole preserve of the authorities (think also of Donald Berwick’s speech to the NHS where his first recommendation for improvement was this – “Put the patient at the absolute centre of your system of care—In its most authentic form, this rule feels very risky to both professionals and managers, especially at first. It means the active presence of patients, families, and communities in the design, management, assessment, and improvement of care. It means total transparency. It means that patients have their own medical records and that restricted visiting hours are eliminated. It means, “Nothing about me without me.”) but more and more information is being shared. The BMJ article, for example, highlights the development of the NHS Choices supersite http://www.nhs.uk and facilities like Healthspace and Medpedia as examples of the much wider publication of health related information.

The second element is collaboration and sharing between individuals. These new tools allow people with similar problems to not only share their experiences but also to discuss what they’ve personally found helpful or harmful.

Demos, a UK-based thinktank has recently published an excellent document entitled “The Talking Cure” which encourages people to think about these changes. In that document they state –

“If we are serious about engaging patients in their own care, we need to recognise that current structures of choice inhibit responsibility.” Choice “requires a genuine negotiation, a conversation between patient and doctor, and a shift in logic.”

and

Truly personalised healthcare allows patients to articulate their experiences, express their values, set their priorities, be aware of their options, exercise their preferences and be educated in managing their health. This means an end to paternalism

The Demos document very interestingly compares the mechanics and hairdressers as models of ways in which doctors work – yes, really!

Today, the typical motorist may have a rough idea of what is wrong with his or her car but leaves it to the mechanic to make an exact diagnosis, define a successful outcome, and prescribe the procedures needed. A visit to the hairdresser on the other hand begins with a conversation to elucidate what the client wants done (and whether it is practical) and may continue throughout the visit. At the end, the client assesses the outcome.

I find all this very exciting. It’s going to shift health care into collaborative relationships which focus on the needs, experiences and wishes of individual patients. This represents a huge challenge to the command and control, expert knows best, model of passive patients who are told what to do by others who claim to know better than the patient what will make their life better.

Read Full Post »

I read a report today by Professor Lipshutz about coenzymeQ10. I don’t know if you’ve heard about it but it’s a chemical which is necessary for the normal functioning of every cell of your body. Given its biological importance, some people have wondered if you can improve function, and therefore health, by giving additional amounts to people as some kind of supplement. The problem with the current supplements is two fold – first coenzymeQ10 has been expensive to make (that’s changed now as the Chinese have developed a cheaper method), and, second, there’s a problem of getting it absorbed into the body. The supplements on the market now tend to deliver only about 10 – 15% of the enzyme. The report I read today is from an American researcher who believes he has come up with a method to tackle this latter problem by using nanotechnology to make coenzymeQ10 easier to deliver effectively to the human body.

OK, so far, this sounds like a good story. If this stuff in needed and giving more of it makes people better then something that improves its availability must just be a good thing. But the question of whether or not taking supplements of coenzymeQ10 will improve your health, either in general, or specifically in relation to particular diseases, hasn’t been clearly answered yet. I agree with the logic expressed by Dr Langsjoen who wrote a very clear summary here. He said –

Modern medicine seems to be based on an “attack strategy”, a philosophy of treatment formed in response to the discovery of antibiotics and the development of surgical/anesthetic techniques. Disease is viewed as something that can be attacked selectively – with antibiotics, chemotherapy, or surgery – assuming no harm to the host. Even chronic illnesses, such as diabetes and hypertension, yield simple numbers which can be furiously assaulted with medications. Amidst the miracles and drama of 20th century medicine we may have forgotten the importance of host support, as if time borrowed with medications and surgery were restorative in and of itself. Yet, in this age, a patient may be cured of leukemia through multiple courses of chemotherapy and bone marrow transplantation, only to die slowly of unrecognized thiamine (vitamin B1) deficiency(47). Like the vitamins discovered in the early part of this century, CoQ10 is an essential element of food that can now be used medicinally to support the sick host in conditions where nutritional depletion and cellular dysfunction occur. Surely, the combination of disease attacking strategy and host supportive treatments would yield much better results in clinical medicine.

There was one particular phrase used by Professor Lipshutz which did alarm me however –

Nature gave us, through 2.5 billion years of evolution, a number of fundamental anti-aging, free-radical scavengers that helped us to survive, on average, only to about 40 years of age, until modern medicine came along

Dear, oh dear. Does Professor Lipshutz really believe that? That life expectancy has increased in the developed world from 40 to 70 years because of “modern medicine”? That’s just not true. And it’s not even what is taught in medical schools. The BIG improvements in life expectancy are not down to medicine at all. They are down to clean water, better housing, improvements in food availability and reductions in absolute and relative poverty. We won’t improve the health of most people by technical fixes. It’s going to need some political will to change our societies.

Read Full Post »

As part of the NHS’s 60th anniversary celebrations, Donald Berwick, President of the US organisation, the Institute for Healthcare Improvement, made a speech at one of the specially organised conferences. I’ve always been impressed by his writing and his speeches. I first encountered them when I read “Crossing the Quality Chasm” – the book which introduced me to the concept of “complex adaptive systems”, and I thoroughly enjoyed his “Escape Fire” ( a collection of ten of his annual addresses ).

His speech, in praise of the NHS, compared it very favourably to the state of health care in the US. In summary, he said this –

You could have had the American plan. You could have been spending 17% of your gross domestic product and making health care unaffordable as a human right instead of spending 9% and guaranteeing it as a human right. You could have kept your system in fragments and encouraged supply driven demand, instead of making tough choices and planning your supply. You could have made hospitals and specialists, not general practice, your mainstay. You could have obscured accountability, or left it to the invisible hand of the market. You could have a giant insurance industry of claims, rules, and paper pushing instead of using your tax base to provide a single route of finance. You could have protected the wealthy and the well instead of recognising that sick people tend to be poorer and that poor people tend to be sicker, and that any healthcare funding plan that is just must redistribute wealth. Britain, you chose well. As troubled as you may believe the NHS to be, as uncertain its future, as controversial its plans, as negative its press, as contentious its politics, please behold the mess that a less ambitious nation could have chosen.

He then went on to make ten suggestions for improvement. The first, I think was the most important and one that most health care systems haven’t even begun to implement on any significant scale –

Put the patient at the absolute centre of your system of care—In its most authentic form, this rule feels very risky to both professionals and managers, especially at first. It means the active presence of patients, families, and communities in the design, management, assessment, and improvement of care. It means total transparency. It means that patients have their own medical records and that restricted visiting hours are eliminated. It means, “Nothing about me without me.”

Apart from that he recommended strenghtening the Primary Care and Community aspects of the service, stopping the habit of more and more “reforms”, a strong plea NOT to pursue a market-led direction (ie I suspect, to do more like the Scottish NHS than the English one), and paying attention to the training and integration of the diverse employees of the NHS. Finally, he recommended aiming at health itself, not just health care.

He is astute enough to know that “great health care, technically delimited, cannot alone produce great health”. Of course it would be nice if the NHS was structured around trying to improve the health of its users, but the real big changes in health as such will be achieved through political means and societal changes, not health care ones.

Read Full Post »

I just read Professor Richard Wilkinson’s “The Impact of Inequality” (ISBN-13: 978-1-59558-121-1). I first read Wilkinson’s work on the impact of inequality on health in the BMJ back in the early 1990s. I found his research remarkable and disturbing at the same time. Essentially what he was highlighting was that in developed countries absolute income levels were not a determinant of health. Instead, what seemed to cause the greatest harm was the size of the gap between rich and poor. In other words, income inequality within a society impacts on many parameters of health, from infant mortality to life expectancy and many disease rates in between. This was a bit puzzling. We mostly believe that poverty, of the kind where your basic material needs of food, water and sanitation are not met, is indeed deadly, but that relative poverty ie the extent to which people feel poor compared to others in society could be deadly? How could that be? Was it true?

Well, over a decade has passed and dozens of more studies have shown the link between inequality and health. In “The Impact of Inequality”, Wilkinson sets out the case very clearly and then provides an explanation for the findings. In a nutshell, he shows that psychosocial stress has an enormous impact on health, and that the key element underpinning this stress is how we think others perceive us. Shame is a strong social force. We feel it when we are not respected, when we are judged to be inferior or to have failed, when we told we are just not “good enough” or when we are dismissed as irrelevant. Social status is the root of much of this shame in all societies, but especially in unequal societies which have strong hierarchies based on dominance and competition. The biological mechanism for this stress is the body’s inflammatory response. When experiencing stress, the human organism activates cellular and hormonal systems to increase defences and prepare the subject for “fight or flight” as a fundamental survival mechanism. Years of such inner responses produces an “allostatic load” – a fairly new measure for the accumulated inflammatory activity. A high allostatic load is associated with an enormous range of chronic diseases.

Let me just cite one example. In societies where there is great economic inequality, blood cholesterol levels are higher than those in more equal societies. These high lipid levels are part of the body’s inflammatory response. The reductionist, technological, “fix” for this is to prescribe statins for more and more people for greater and greater proportions of their lives. This isn’t exactly a matter of stable doors and bolted horses but even if the statins do what they say on the tin, the problem just shifts elsewhere. Unequal societies experience lower life expectancy, particularly in those who live in the poorest strata. If they don’t die early from heart disease, they die early from something else. The answer, if we take on board what Wilkinson shows us, is political. It’s about creating more humane, more caring, more “affiliative” societies by tackling the fundamental issue of inequality.

Read Full Post »

Clinical epidemiology has been cleverly spun into something referred to as “Evidence Based Medicine” (“EBM”). It’s such a powerful spin that we are seeing the term “evidence based” being used widely now to justify any decision made by any authority – whether that be politicians, civil servants, educators or scientists. In fact, the phrase is thrown around so freely and unthinkingly that it’s quickly losing its original meaning, instead becoming a code term for “fact” or undeniable Truth. “Evidence based” is a label now which is supposed to convey that the statement to which it is attached has a high value. The idea of “evidence based” as promoted by those who use the term is founded on the belief that what constitutes “truth” is, however, almost exclusively, the physical and the measurable. Let me quote from  Maya Goldenberg, who wrote about this in Social Science and Medicine. Volume 62, Issue 11, June 2006 –

Reflecting on how the popular idea of “patient-centred care” remains largely unrealized in clinical practice, Van Weel and Knottneurus (1999) note that while physicians are encouraged to make diagnoses in physical, psychological, and social terms, “the EBM that is currently promoted either restricts itself to physical evidence alone, or casts such evidence at the top of a hierarchy that tends to devalue any evidence ‘lower down’”. The hierarchy of evidence promotes a certain scientistic accounting of the goals of medicine, which, the worry goes, is incommensurable with the proposed reorientation of medical practice toward the patient’s search for meaning in the illness experience. The bridging of scientistic “measure” and existential “meaning” has received some attention in the critical EBM literature with the general consensus that we need an “integrated” model of evidence that properly reflects modern health care’s constitution by diverse academic traditions—including the humanities, social sciences, and the pure and applied sciences—that rely on equally diverse notions of evidence. While EBM values evidence that is statistical in nature and general in its application, and therefore places quantitative data derived through the application of recognised study designs at the top of its pre-graded hierarchies of evidence, the phenomenological approaches rooted in hermeneutics, ethnography, sociology, and anthropology, regard evidence as primarily narrative, subjective, and historical in nature. Unlike the impersonal and generalisable measures undertaken in EBM, this conception of evidence is illustrated in case histories, clinical encounters, and qualitative studies such as in-depth interviews and focus groups. The features of the medical encounter and the illness experience emphasised by medical phenomenologists and proponents of a more “humane” medicine suggest the need to reconsider what constitutes the goals of medicine and flip EBM’s hierarchy of evidence on its head. The quantitative measures and generalisations that come out of controlled trials and biostatistical analysis are not conducive to the questions of meaning that medical phenomenology wants to address and make central to medicine.

Goldenberg helpfully nails down the key issues – “ While EBM values evidence that is statistical in nature and general in its application, and therefore places quantitative data derived through the application of recognised study designs at the top of its pre-graded hierarchies of evidence, the phenomenological approaches rooted in hermeneutics, ethnography, sociology, and anthropology, regard evidence as primarily narrative, subjective, and historical in nature” – The EBM approach is a statistical approach. It tells us something about probabilities, derived from studies of large, supposedly homogenous groups. It doesn’t give us certainty about either effectiveness of a treatment, or about prognosis, in any individual patient. Nor does it give us any insights into either the experience of illness, or the experience of therapeutic recovery for patients.
The use of clinical epidemiology alone in the application of health policy or therapeutic practice is neither rational nor sensible. Health and illness are experiential. Human experiences can only be conveyed by human beings. If we want a more humane form of medical practice which is a closer fit with individual reality then we need to develop our phenomenological understanding and give such research considerably greater consideration than we currently do instead of dismissing the unquantifiable as irrelevant.

Read Full Post »

« Newer Posts - Older Posts »